Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001926373 | SCV002207326 | pathogenic | Cohen syndrome | 2021-10-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This variant is present in population databases (rs567092790, ExAC 0.01%). This sequence change creates a premature translational stop signal (p.Gln1008*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Fulgent Genetics, |
RCV001926373 | SCV005672020 | likely pathogenic | Cohen syndrome | 2024-06-20 | criteria provided, single submitter | clinical testing |